These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24901824)

  • 1. A distinct pattern of disease-associated single nucleotide polymorphisms in IBD risk genes in a family with Crohn's disease.
    Barthel C; Spalinger MR; Brunner J; Lang S; Fried M; Rogler G; Scharl M
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):803-6. PubMed ID: 24901824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
    Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
    Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease.
    van der Heide F; Nolte IM; Kleibeuker JH; Wijmenga C; Dijkstra G; Weersma RK
    Am J Gastroenterol; 2010 May; 105(5):1165-72. PubMed ID: 19953089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn's Disease: On the Way to Personalized Medicine?
    Hoffmann P; Lamerz D; Hill P; Kirchner M; Gauss A
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34198814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2 sequencing in Iranian children with Crohn's disease.
    Motamed F; Najafi M; Taghvaei M; Moazzami K; Farahmand F; Khodadad A; Fallahi GH; Parvaneh N; Khatami GR; Rezaei N
    Z Gastroenterol; 2011 Jul; 49(12):1526-8. PubMed ID: 22139875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
    Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
    Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population.
    Morgan AR; Han DY; Huebner C; Lam WJ; Fraser AG; Ferguson LR
    Tissue Antigens; 2010 Aug; 76(2):119-25. PubMed ID: 20403149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
    Weersma RK; Stokkers PC; Cleynen I; Wolfkamp SC; Henckaerts L; Schreiber S; Dijkstra G; Franke A; Nolte IM; Rutgeerts P; Wijmenga C; Vermeire S
    Am J Gastroenterol; 2009 Mar; 104(3):630-8. PubMed ID: 19174780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes.
    Lauriola M; Ugolini G; Rivetti S; Nanì S; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Belluzzi A; Castellani L; D'Uva G; Mattei G; Taffurelli M; Strippoli P; Solmi R
    Int J Mol Med; 2011 Mar; 27(3):469-77. PubMed ID: 21206965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.
    Glas J; Wagner J; Seiderer J; Olszak T; Wetzke M; Beigel F; Tillack C; Stallhofer J; Friedrich M; Steib C; Göke B; Ochsenkühn T; Karbalai N; Diegelmann J; Czamara D; Brand S
    PLoS One; 2012; 7(3):e33682. PubMed ID: 22457781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
    Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
    BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic risk profiling and gene signature modeling to predict risk of complications after IPAA.
    Sehgal R; Berg A; Polinski JI; Hegarty JP; Lin Z; McKenna KJ; Stewart DB; Poritz LS; Koltun WA
    Dis Colon Rectum; 2012 Mar; 55(3):239-48. PubMed ID: 22469789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
    Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.
    Ferguson LR; Han DY; Fraser AG; Huebner C; Lam WJ; Morgan AR; Duan H; Karunasinghe N
    Mutat Res; 2010 Aug; 690(1-2):108-15. PubMed ID: 20109474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.